RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

TFA Therapeutics, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026

$9.18+0.00 (0.00%)

Close on Oct 16, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

TFA Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements TFA Therapeutics filed with the SEC

Parsed from the XBRL in TFA Therapeutics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RAJAF.

Revenue growth-0.6% · median -21.7%

Gross margin61.1% · median 31.7%

Operating margin-11.3% · median -110.9%

Net margin-12.4% · median -150.4%

Advertisement
300 × 250